Rossari Biotech Limited — Board Meeting, 19-10-2024: Outcome of Board Meeting

Rossari Biotech Limited has announced its Board Meeting outcomes, including the approval of unaudited financial results for the quarter and half-year ending September 30, 2024, demonstrating robust revenue growth. The company appointed Mr. Gurudas Aras as an Independent Director for three years and recommended the re-appointment of Mr. Aseem Dhru. Additionally, a wholly-owned subsidiary will acquire Unistar Thai Co. Limited. An Extraordinary General Meeting is scheduled for November 11, 2024, for member approvals.